查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446969

到 2030 年高压显影剂注射器的全球市场预测：按产品类型、应用、最终用户和地区进行分析

High Pressure Contrast Media Injector Market Forecasts to 2030 - Global Analysis By Product (Injector Systems and Consumables), Type (Single Head Injectors, Syringeless Injectors and Dual Head Injectors), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

据Stratistics MRC称，2023年全球高压显影剂注射器市场规模将达到1.776亿美元，预计到2030年将达到4.472亿美元，预测期内复合年增长率为14.1%。

高压显影剂是用于放射学和成像程序的医疗设备，特别是电脑断层扫描 (CT) 扫描和血管造影术。该装置通常由含有显影剂的注射器或储液器、高压注射器系统和电脑控制面板组成。这些注射器以受控的速率和压力输送显影剂，确保在整个脉管系统中一致且均匀的分布。其结果是提高了血管、器官和组织的可见度，从而产生更清晰、更详细的影像。

根据世界卫生组织（WHO）的估计，癌症是世界上大多数国家的主要原因之一。

微创手术需求不断成长

微创手术技术因其与传统开放性手术相比的潜在优势而越来越受欢迎。随着微创手术在各个医疗领域变得普及普遍，在这些手术过程中对高品质影像导引的需求变得至关重要。此外，高压显影剂输液设备在血管内治疗、介入放射学和腹腔镜手术等微创手术中的血管、器官和组织的即时可视化中发挥重要作用。

不利事件的风险

高压显影剂注射器是一种将显影剂直接注入患者血液的医疗设备。因此，存在与显影剂给药相关的不利事件的风险，例如过敏反应、血管外浸润和过敏反应。此外，显影剂肾臟病是一种潜在的併发症，其特征是显影剂暴露后的急性肾损伤，尤其是有肾功能不全病史的患者。不利事件的发生可能会导致患者受伤、医疗成本增加以及医疗保健提供者和设施的责任风险。这些因素限制了市场的扩张。

成像技术的进步

随着成像技术的发展并变得更加复杂，对造影增强成像程序以提供详细且准确的诊断资讯的需求日益增加。高压显影剂注射器是造影剂增强成像程序的重要组成部分，因为它们可以以精确且受控的方式可靠地将显影剂显影剂输送到患者的血流中。此外，以高压和受控速率注射显影剂显影剂优化其在整个脉管系统中的分布，从而可以清晰地显示解剖结构和异常情况。因此，影像处理技术的进步已成为市场扩张的主要因素。

与替代显像模式的衝突

超音波、磁振造影(MRI) 和光同调断层扫瞄(OCT) 等方式可提供详细的解剖和功能信息，而无需注射造影显影剂。这些替代成像方式比显影剂增强成像方式具有优势，包括降低副作用风险和避免电离辐射暴露。因此，医疗保健提供者可能会越来越多地选择替代成像方式而不是显影剂注射技术，从而可能减少对高压显影剂注射器的需求。

COVID-19 的影响

COVID-19 大流行对高压显影剂剂注射器市场产生了负面影响。世界各地的医疗保健系统因 COVID-19 患者的涌入而不堪重负，导致包括诊断成像在内的非紧急医疗程序被推迟或取消，并且对显影剂的需求减少。此外，许多医院和诊断影像中心也面临人员短缺、供应链中断和财务限制等营运挑战。

预计消耗品领域在预测期内将是最大的

消耗品部分估计占最大份额。耗材在支援显影剂注射系统的操作和功能方面发挥关键作用。注射器是一种重要的消耗品，用于容纳显影剂并将其输送到注射系统。此外，它们具有多种尺寸和配置，以适应不同的注射量和流速。因此，对耗材的需求是一致的，并且与临床中高压显影剂的使用密切相关。

预计单头注射器细分市场在预测期内复合年增长率最高

预计单头注射器细分市场在预测期内将出现良好的成长。这些注射器旨在透过单一注射头或註射器以受控的速率和压力将显影剂输送到患者的血流中。此外，这些注射器简单易用，适合医疗保健环境中的常规影像处理。这些注射器旨在以最小的变化提供精确数量的显影剂，确保影像检查中一致的影像品质和诊断准确性。

占比最高的地区

凭藉先进的医疗基础设施、技术创新和诊断成像的高需求，北美在预测期内占据了最大的市场占有率。该地区包括美国、加拿大和墨西哥，拥有大量医疗支出，并专注于医疗进步和患者护理。此外，北美的技术进步和研发工作正在促进高压显影剂技术的持续发展。

复合年增长率最高的地区：

预计欧洲在预测期内将出现盈利成长。欧洲医疗保健基础设施的特点是拥有完善的医院、诊断影像中心和学术机构，提供最先进的诊断影像程序。此外，该地区也是几家主要医疗设备製造商的所在地，其中包括高压显影剂注射器。这些公司利用该地区强大的研发能力、监管专业知识和品质标准来开发创新註射器技术，以满足医疗保健专业人员和患者的需求。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球高压显影剂注射器市场：按产品

  • 注射器系统
  • 消耗品
    • 管子
    • 注射器

第六章全球高压显影剂注射器市场：按类型

  • 单头注射器
  • 无注射器注射器
  • 双头注射器

第七章全球高压显影剂注射器市场：依应用分类

  • 介入放射学
  • 血管内手术
  • 介入性心臟病学
  • 其他用途

第八章全球高压显影剂注射器市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 诊断中心

第九章全球高压显影剂注射器市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Guerbet Group
  • Bayers Healthcare LLC
  • Bracco Group
  • Ulrich GmbH & Co. KG
  • Medtron AG
  • GE Healthcare
  • NemotoKyorindo Co. Ltd
  • Apollo RT Co. Ltd
  • Vivid Imaging
  • Sino Medical Device Technology Co.
Product Code: SMRC25230

According to Stratistics MRC, the Global High Pressure Contrast Media Injector Market is accounted for $177.6 million in 2023 and is expected to reach $447.2 million by 2030 growing at a CAGR of 14.1% during the forecast period. A high-pressure contrast media injector is a medical device used in radiology and diagnostic imaging procedures, particularly computed tomography (CT) scans and angiography. The device typically consists of a syringe or reservoir containing the contrast media, a high-pressure injector system, and a computerized control panel. These injectors deliver contrast media at a controlled rate and pressure, ensuring consistent and uniform distribution throughout the vascular system. This results in improved visualization of blood vessels, organs, and tissues, leading to clearer and more detailed images.

According to the World Health Organization (WHO) estimates, cancer is the one of the leading causes of death in majority of countries globally.

Market Dynamics:

Driver:

Rising demand for minimally invasive surgeries

Minimally invasive surgical techniques have gained popularity due to their potential benefits compared to traditional open surgeries. As minimally invasive procedures become more widespread across various medical specialties, the need for high-quality imaging guidance during these procedures becomes paramount. Additionally, high-pressure contrast media injectors play a crucial role in providing real-time visualization of blood vessels, organs, and tissues during minimally invasive surgeries, such as endovascular procedures, interventional radiology, and laparoscopic surgeries.

Restraint:

Risk of adverse events

High-pressure contrast media injectors are medical devices that administer contrast agents directly into the patient's bloodstream. As such, there is a risk of adverse events associated with contrast administration, such as allergic reactions, extravasation, and anaphylaxis. Furthermore, contrast-induced nephropathy is a potential complication characterized by acute kidney injury following contrast media exposure, particularly in patients with pre-existing renal impairment. The occurrence of adverse events can result in patient harm, increased healthcare costs, and liability risks for healthcare providers and facilities. These factors limit the market's expansion.

Opportunity:

Advancements in imaging technologies

As imaging technologies evolve and become more sophisticated, there is a growing need for contrast-enhanced imaging procedures to provide detailed and accurate diagnostic information. High-pressure contrast media injectors are essential components in contrast-enhanced imaging procedures, as they ensure the precise and controlled delivery of contrast agents into the patient's bloodstream. Moreover, by delivering contrast media at high pressures and controlled rates, these injectors optimize the distribution of contrast agents throughout the vascular system, enabling clearer visualization of anatomical structures and abnormalities. As a result, advancements in imaging technologies are a significant factor propelling market expansion.

Threat:

Competition from alternative imaging modalities

Modalities such as ultrasound, magnetic resonance imaging (MRI), and optical coherence tomography (OCT) provide detailed anatomical and functional information without the need for Injectable contrast media. These alternative imaging modalities offer advantages over contrast-enhanced imaging techniques, including reduced risk of adverse reactions and avoidance of ionizing radiation exposure. As a result, healthcare providers may increasingly opt for alternative imaging modalities over contrast-enhanced techniques, leading to a decline in demand for high-pressure contrast media injectors.

Covid-19 Impact

The COVID-19 pandemic had negatively impacted the high-pressure contrast media injector market. With healthcare systems worldwide overwhelmed by the influx of COVID-19 patients, non-urgent medical procedures, including diagnostic imaging, have been postponed or cancelled, leading to a decline in demand for contrast media injectors. Moreover, many hospitals and imaging centers faced operational challenges, such as staffing shortages, supply chain disruptions, and financial constraints.

The consumables segment is expected to be the largest during the forecast period

The consumables segment is estimated to hold the largest share. Consumables play a crucial role in supporting the operation and functionality of contrast media injection systems. Syringes are essential consumables that hold and deliver the contrast media to the injector system. Moreover, they come in various sizes and configurations to accommodate different injection volumes and flow rates. As a result, demand for consumables remains consistent and is closely related to the use of high-pressure contrast media injectors in clinical practice.

The single head injectors segment is expected to have the highest CAGR during the forecast period

The single head injectors segment is anticipated to have lucrative growth during the forecast period. These injectors are designed to deliver contrast media into the patient's bloodstream at a controlled rate and pressure through a single injection head or syringe. Furthermore, these injectors offer simplicity and ease of use, making them suitable for routine imaging procedures in healthcare settings. They are engineered to deliver precise volumes of contrast media with minimal variability, ensuring consistent image quality and diagnostic accuracy across imaging studies.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to its advanced healthcare infrastructure, technological innovation, and high demand for diagnostic imaging procedures. The region encompasses the United States, Canada, and Mexico, where healthcare expenditure is substantial and there is a strong emphasis on medical advancements and patient care. Moreover, technological advancements and research and development initiatives in North America contribute to the continuous evolution of high-pressure contrast media injector technologies.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period. Europe's healthcare infrastructure is characterized by well-established hospitals, imaging centers, and academic institutions, providing access to state-of-the-art diagnostic imaging procedures. Furthermore, the region is home to several leading manufacturers of medical devices, including high-pressure contrast media injectors. These companies leverage the region's strong research and development capabilities, regulatory expertise, and quality standards to develop innovative injector technologies that meet the needs of healthcare providers and patients.

Key players in the market

Some of the key players in the High Pressure Contrast Media Injector Market include Guerbet Group, Bayers Healthcare LLC, Bracco Group, Ulrich GmbH & Co. KG, Medtron AG, GE Healthcare, NemotoKyorindo Co. Ltd, Apollo RT Co. Ltd, Vivid Imaging and Sino Medical Device Technology Co.

Key Developments:

In September 2023, GE HealthCare and Mayo Clinic announced a strategic healthcare collaboration for research and product development programs aimed to transform the experience of patients and clinicians in the practice of radiology and the delivery of novel therapies.

In December 2022, Bayer announced the U.S. launch of the Bayer Science Collaboration Explorer (BSCE) as part of its ongoing efforts to enhance public trust in scientific innovations, processes, and R&D activities.

In November 2022, GE Healthcare announced agreement with ulrich medical aimed at enhancing its market position in the growing U.S. market. As per the agreement, these two companies will co-ordinate to develop and offer multi-dose contrast media injector in the country.

In March 2022, Bracco Imaging and Philochem, a subsidiary of the Philogen Group collaborated on the development of a molecule for diagnostic applications

In December 2021, Bracco Imaging announced a global strategic collaboration agreement with Guerbet for Gadopiclenol, a high-relaxivity, macrocyclic contrast agent. Bracco Imaging and Guerbet will manufacture, as well as support research and development for future indications of Gadopiclenol, which the parties will commercialize independently under different brands.

Products Covered:

  • Injector Systems
  • Consumables

Types Covered:

  • Single Head Injectors
  • Syringeless Injectors
  • Dual Head Injectors

Applications Covered:

  • Interventional Radiology
  • Endovascular Surgery
  • Interventional Cardiology
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Diagnostic Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global High Pressure Contrast Media Injector Market, By Product

  • 5.1 Introduction
  • 5.2 Injector Systems
  • 5.3 Consumables
    • 5.3.1 Tubing
    • 5.3.2 Syringes

6 Global High Pressure Contrast Media Injector Market, By Type

  • 6.1 Introduction
  • 6.2 Single Head Injectors
  • 6.3 Syringeless Injectors
  • 6.4 Dual Head Injectors

7 Global High Pressure Contrast Media Injector Market, By Application

  • 7.1 Introduction
  • 7.2 Interventional Radiology
  • 7.3 Endovascular Surgery
  • 7.4 Interventional Cardiology
  • 7.5 Other Applications

8 Global High Pressure Contrast Media Injector Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals
  • 8.4 Diagnostic Centers

9 Global High Pressure Contrast Media Injector Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Guerbet Group
  • 11.2 Bayers Healthcare LLC
  • 11.3 Bracco Group
  • 11.4 Ulrich GmbH & Co. KG
  • 11.5 Medtron AG
  • 11.6 GE Healthcare
  • 11.7 NemotoKyorindo Co. Ltd
  • 11.8 Apollo RT Co. Ltd
  • 11.9 Vivid Imaging
  • 11.10 Sino Medical Device Technology Co.

List of Tables

  • Table 1 Global High Pressure Contrast Media Injector Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 4 Global High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 5 Global High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 6 Global High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 7 Global High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 8 Global High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 9 Global High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 10 Global High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 11 Global High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 13 Global High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 14 Global High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 15 Global High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 16 Global High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 17 Global High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 18 Global High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 19 Global High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 20 North America High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 21 North America High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 22 North America High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 23 North America High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 24 North America High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 25 North America High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 26 North America High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 27 North America High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 28 North America High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 29 North America High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 30 North America High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 31 North America High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 32 North America High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 33 North America High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 34 North America High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 35 North America High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 36 North America High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 37 North America High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 38 North America High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 39 Europe High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 40 Europe High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 41 Europe High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 42 Europe High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 43 Europe High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 44 Europe High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 45 Europe High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 46 Europe High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 47 Europe High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 48 Europe High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 49 Europe High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 50 Europe High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 51 Europe High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 52 Europe High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 53 Europe High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 54 Europe High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 55 Europe High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 56 Europe High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 57 Europe High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 58 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 59 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 60 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 61 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 62 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 63 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 64 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 65 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 66 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 67 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 68 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 69 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 70 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 71 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 72 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 73 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 74 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 75 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 76 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 77 South America High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 78 South America High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 79 South America High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 80 South America High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 81 South America High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 82 South America High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 83 South America High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 84 South America High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 85 South America High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 86 South America High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 87 South America High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 88 South America High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 89 South America High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 90 South America High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 91 South America High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 92 South America High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 93 South America High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 94 South America High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 95 South America High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 96 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 97 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 98 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 99 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 100 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 101 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 102 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 103 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 104 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 105 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 106 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 107 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 108 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 109 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 110 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 111 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 112 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 113 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 114 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)